FNY Partners Fund LP - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 78 filers reported holding NEOS THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 21.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
FNY Partners Fund LP ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$71,000
-18.4%
7,000
-42.2%
0.01%
+20.0%
Q1 2017$87,00012,1180.01%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,962,657$3,100,0002.37%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 100,000$62,0000.02%
SlateStone Wealth, LLC 62,000$39,0000.01%
Allred Capital Management, LLC 24,995$15,0000.01%
Bridge Advisory, LLC 23,564$15,0000.01%
Livingston Group Asset Management CO (operating as Southport Capital Management) 24,000$15,0000.01%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 320,993$201,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 229,500$143,0000.00%
Virtu Financial LLC 41,401$26,0000.00%
TSFG, LLC 200$1,0000.00%
View complete list of NEOS THERAPEUTICS INC shareholders